Review

Liver fibrosis

Volume 29 · Issue 1 Publish Date: January 15, 2018
Full Text PDF
DOI
M. Merve Aydın
Mikrogen Genetic Diagnostic Laboratory, Ankara, Turkey
Kamil Can Akçalı
Department of Biophysics, Ankara University, School of Medicine, Ankara, Turkey
Aydın, M. M., & Akçalı, K. C. (2018). Liver fibrosis. Turkish Journal of Gastroenterology, 29(1), 14–21. https://doi.org/10.5152/tjg.2018.17330
Full Text Full Text PDF

Abstract

Abstract Liver fibrosis is a wound-healing response generated against an insult to the liver that causes liver injury. It has the potential to progress into cirrhosis, and if not prevented, it may lead to liver cancer and liver failure. The activation of hepatic stellate cells (HSCs) is the central event underlying liver fibrosis. In addition to HSCs, numerous studies have supported the potential contribution of bone marrow-derived cells and myofibroblasts to liver fibrosis. The liver is a heterogeneous organ; thus, molecular and cellular events that underlie liver fibrogenesis are complex. This review aims to focus on major events that occur during liver fibrogenesis. In addition, important antifibrotic therapeutic approaches and experimental liver fibrosis models will be discussed. Cite this article as: Aydın MM, Akçalı KC. Liver fibrosis. Turk J Gastroenterol 2018; 29: 13-20.

Most read articles by the same author(s)

Article Info
Published In
Journal Turkish Journal of Gastroenterology
Volume / Issue Volume 29 · Issue 1
Pages 14-21
History
Published Online January 15, 2018
Copyright
Affiliations
M. Merve Aydın
Mikrogen Genetic Diagnostic Laboratory, Ankara, Turkey
Kamil Can Akçalı
Department of Biophysics, Ankara University, School of Medicine, Ankara, Turkey
Cite this Article
Aydın, M. M., & Akçalı, K. C. (2018). Liver fibrosis. Turkish Journal of Gastroenterology, 29(1), 14–21. https://doi.org/10.5152/tjg.2018.17330
Outlines